Outlook Therapeutics Announces Agreements to Streamline Capital Structure and Regain 100% Ownership of Any Future Net Profits for ONS-5010GlobeNewsWire • 01/28/20
Outlook Therapeutics Announces Warrant Amendment and Restructuring of Senior Secured Notes in Separate TransactionsGlobeNewsWire • 12/23/19
Outlook Therapeutics Receives FDA Agreement for Three Special Protocol Assessments for Additional Planned Clinical Trials of ONS-5010GlobeNewsWire • 12/03/19
Outlook Therapeutics to Present at the 29th Annual Ladenburg Thalmann 2019 Healthcare ConferenceGlobeNewsWire • 09/11/19
Outlook Therapeutics: A Perfect Storm Of Positive Catalysts Driving Share Price UpSeeking Alpha • 05/20/19
Outlook Therapeutics stock rockets on heavy volume again, set to triple in 3 daysMarket Watch • 05/20/19
Outlook Therapeutics' stock rockets on heavy volume again, has more than doubled in 2 daysMarket Watch • 05/17/19